On November 11, 2025, in Beijing, Medimscience Biomedical Technology is honored to sign a cooperation intention agreement with Merck's R&D China Innovation Cooperation Center. As one of the world's most important MNCs in the field of...
View MoreHangzhou Medimscience Biomedical Technology Co., Ltd. recently announced the completion of a new round financing of tens of millions of RMB. Medimscience Bio. is the pioneer emerging biotechnology enterprise focusing on the development of biopharmace...
View MoreMedimscience Bio. is the pioneer domestic emerging biotechnology enterprise in China focusing on the development of new target drugs for macrophages. Immunotherapy drugs are currently the most important treatments for cancers and autoimmune diseases,...
View More